122 related articles for article (PubMed ID: 6632176)
1. The effect of sodium depletion on plasma norepinephrine kinetics in patients with essential hypertension.
Kimura S; Miura Y; Adachi M; Adachi M; Nezu M; Toriyabe S; Sugawara T; Ishizuka Y; Noshiro T; Takahashi M
Jpn Circ J; 1983 Oct; 47(10):1232-41. PubMed ID: 6632176
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary potassium on the hemodynamics and plasma norepinephrine kinetics in patients with essential hypertension.
Ohashi H; Miura Y; Kimura S; Ishizuka Y; Sugawara T; Toriyabe S; Noshiro T; Takahashi M; Sano N; Watanabe H
Jpn Circ J; 1985 Sep; 49(9):1019-27. PubMed ID: 4068199
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension.
Rumantir MS; Kaye DM; Jennings GL; Vaz M; Hastings JA; Esler MD
Hypertension; 2000 Nov; 36(5):824-9. PubMed ID: 11082150
[TBL] [Abstract][Full Text] [Related]
4. Norepinephrine clearance and pressor effect in normal and hypertensive man.
Grimm M; Weidmann P; Keusch G; Meier A; Glück Z
Klin Wochenschr; 1980 Nov; 58(21):1175-81. PubMed ID: 7453102
[TBL] [Abstract][Full Text] [Related]
5. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension.
Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S
Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine kinetics in dogs with experimentally induced renal vascular hypertension.
Buranakarl C; Benjanirut C; Pondeenana S; Bovée KC
Am J Vet Res; 2000 Dec; 61(12):1534-41. PubMed ID: 11131595
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine responsiveness in patients with borderline hypertension under three different sodium balances.
Ito Y; Noda H; Isaka M; Ando K; Sato Y; Fujita T
Clin Exp Hypertens A; 1989; 11 Suppl 1():363-70. PubMed ID: 2743598
[TBL] [Abstract][Full Text] [Related]
8. Total plasma clearance of infused norepinephrine in non-azotemic diabetes mellitus.
Beretta-Piccoli C; Weidmann P
Klin Wochenschr; 1982 Jun; 60(11):555-60. PubMed ID: 7109495
[TBL] [Abstract][Full Text] [Related]
9. [Effect of aging on blood catecholamine under 3 conditions of sodium intake--comparison between normal subjects and patients with essential hypertension].
Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
Nihon Naibunpi Gakkai Zasshi; 1983 Sep; 59(9):1276-85. PubMed ID: 6642012
[TBL] [Abstract][Full Text] [Related]
10. Norepinephrine infusion in normal subjects and patients with essential or renal hypertension: effect on blood pressure, heart rate, and plasma catecholamine concentrations.
Manger WM; Frohlich ED; Gifford RW; Dustan HP
J Clin Pharmacol; 1976; 16(2-3):129-41. PubMed ID: 943425
[TBL] [Abstract][Full Text] [Related]
11. [The role of prostaglandins for norepinephrine clearance in borderline hypertension].
Koshida H; Miyamori I; Nagai K; Ikeda M; Takeda Y; Yasuhara S; Morise T; Takimoto H; Hifumi S; Takeda R
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1193-201. PubMed ID: 6519311
[TBL] [Abstract][Full Text] [Related]
12. Estimation of sympathetic activity in essential hypertension.
Brown MJ; Lhoste FJ; Zamboulis C; Ind PW; Jenner DA; Dollery CT
Clin Pharmacol Ther; 1982 Jan; 31(1):16-22. PubMed ID: 7053299
[TBL] [Abstract][Full Text] [Related]
13. The baroreflex-mediated changes in plasma norepinephrine and heart rate in patients with essential hypertension.
Ishizuka Y; Miura Y; Kimura S; Ohashi H; Sugawara T; Watanabe H; Noshiro T; Takahashi M; Sano N; Yoshinaga K
Jpn Circ J; 1987 Oct; 51(10):1165-73. PubMed ID: 3430687
[TBL] [Abstract][Full Text] [Related]
14. The role of sympathetic activity in normal renin essential hypertension.
Eng FW; Huber-Smith M; McCann DS
Hypertension; 1980; 2(1):14-9. PubMed ID: 6989754
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma norepinephrine in young patients with essential hypertension under three sodium intakes.
Masuo K; Ogihara T; Kumahara Y; Yamatodani A; Wada H
Hypertension; 1984; 6(3):315-21. PubMed ID: 6735453
[TBL] [Abstract][Full Text] [Related]
16. The effects of race on norepinephrine clearance.
Ziegler MG; Mills PJ; Dimsdale J
Life Sci; 1991; 49(6):427-33. PubMed ID: 1865747
[TBL] [Abstract][Full Text] [Related]
17. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
[TBL] [Abstract][Full Text] [Related]
18. The effects of epinephrine on norepinephrine release in essential hypertension.
Nezu M; Miura Y; Adachi M; Adachi M; Kimura S; Toriyabe S; Ishizuka Y; Ohashi H; Sugawara T; Takahashi M
Hypertension; 1985; 7(2):187-95. PubMed ID: 3980065
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics.
Veith RC; Lewis N; Linares OA; Barnes RF; Raskind MA; Villacres EC; Murburg MM; Ashleigh EA; Castillo S; Peskind ER
Arch Gen Psychiatry; 1994 May; 51(5):411-22. PubMed ID: 8179465
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients.
Esler M; Jackman G; Bobik A; Leonard P; Kelleher D; Skews H; Jennings G; Korner P
Hypertension; 1981; 3(2):149-56. PubMed ID: 7216371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
